Latest Articles

  • Bone turnover markers to monitor oral bisphosphonate therapy
    Nikita Ashcherkin, MD, Archna A. Patel, MD, MPH, Alicia Algeciras-Schimnich, PhD and Krupa B. Doshi, MD, FACE
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 26-31; DOI: https://doi.org/10.3949/ccjm.90a.22002

    Rapid changes in levels of bone turnover markers can be useful in monitoring the effectiveness of therapy and improving adherence to therapy.

  • Update in cutaneous manifestations of COVID-19: Special populations
    Update in cutaneous manifestations of COVID-19: Special populations
    Samantha Polly, MD, Inga M. Muser, MD and Anthony P. Fernandez, MD, PhD
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 43-52; DOI: https://doi.org/10.3949/ccjm.90a.22013

    Recognition of skin reactions and their implications is beneficial to clinicians in shaping patient counseling and anticipatory guidance. An illustrated guide.

  • Statins may increase diabetes, but benefit still outweighs risk
    Byron J. Hoogwerf, MD, FACP, FACE
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 53-62; DOI: https://doi.org/10.3949/ccjm.90a.22069

    The weight of the evidence suggests that statin use is associated with an increased risk of new-onset diabetes mellitus, but the magnitude of the effect has varied across studies.

  • Which patients hospitalized with alcohol withdrawal syndrome should receive high-dose parenteral thiamine?
    Rahul B. Ganatra, MD, MPH, Anthony C. Breu, MD and Matthew V. Ronan, MD
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 22-25; DOI: https://doi.org/10.3949/ccjm.90a.22026

    The authors briefly outline risk factors for Wernicke encephalopathy and when high-dose parenteral thiamine is indicated.

  • Making best use of bone turnover markers to monitor oral bisphosphonate therapy
    Sarah Keller, MD
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 32-34; DOI: https://doi.org/10.3949/ccjm.90a.22092

    Clinical applications of bone turnover markers can include determining when to start or end a bisphosphonate “holiday” and measuring treatment response.

  • Median rhomboid glossitis caused by tongue-brushing
    Tatsuya Shindo, MD
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 15-16; DOI: https://doi.org/10.3949/ccjm.90a.21111

    The patient had started vigorous brushing 1 month earlier after being told that she had bad breath.

  • What are my obligations to my incarcerated patient?
    Farah Acher Kaiksow, MD, MPP, Deval Patel, MD and Norman Fost, MD, MPH
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 18-21; DOI: https://doi.org/10.3949/ccjm.90a.22003

    A court order authorizes a blood transfusion, but the incarcerated patient refuses the transfusion. As the caregiver, am I obligated to follow the court order against the patient’s wishes?

  • Central vision loss in a 44-year-old woman
    Walker M. Schmidt, BS, Nirosha D. Perera, MD, Blake H. Fortes, MD, Benjamin A. Nelson, MD, Wendy M. Smith, MD and Hannah C. Nordhues, MD
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 35-41; DOI: https://doi.org/10.3949/ccjm.90a.22038

    The patient had a wide range of symptoms and comorbidities, resulting in a complicated differential diagnosis. Careful evaluation eventually led to a focus on sexually transmitted infection.

  • On the horizon: Extracorporeal carbon dioxide removal
    On the horizon: Extracorporeal carbon dioxide removal
    Justin Hanks, DO, Steven Fox, MD, Omar Mehkri, MD, Laura W. Lund, PhD, Tracey Dill, RRT, Abhijit Duggal, MD, MPH, MSc and Sudhir Krishnan, MD
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 712-718; DOI: https://doi.org/10.3949/ccjm.89a.21084

    Extracorporeal carbon dioxide removal to treat hypercapnic respiratory failure has been studied in acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and other conditions.

  • Evaluation and management of gastroesophageal reflux disease: A brief look at the updated guidelines
    Priya Sasankan, MD and Prashanthi N. Thota, MD, FACG
    Cleveland Clinic Journal of Medicine December 2022, 89 (12) 700-703; DOI: https://doi.org/10.3949/ccjm.89a.22059

    Updated guidelines from the American College of Gastroenterology address the evaluation and management of reflux disease, consequences of long-term PPI therapy, and emerging therapies.

Pages